Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...
Verywell Health on MSN2mon
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant DepressionThe Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback